Ignite Creation Date:
2024-05-06 @ 12:20 PM
Last Modification Date:
2024-10-26 @ 12:57 PM
Study NCT ID:
NCT03735966
Status:
COMPLETED
Last Update Posted:
2022-12-01
First Post:
2018-11-05
Brief Title:
Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Docetaxel and Carboplatin in HER2 Positive Breast Cancer Patients
Sponsor:
Organization:
Henan Cancer Hospital